CA 15-3 is a predictive and prognostic biomarker in patients with metastasized breast cancer undergoing Selective Internal Radiation Therapy

Related Experiment Video

Updated: May 15, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

Yvonne Nadine Fahmueller¹, Dorothea Nagel, Ralf-Thorsten Hoffmann

¹Institute of Clinical Chemistry, University-Hospital Munich-Grosshadern, Munich, Germany.

International Journal of Clinical Pharmacology and Therapeutics

|December 25, 2012

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Early liver parameter increase after transjugular intrahepatic portosystemic shunt (TIPS): hepatic vascular risk factors and development of an exploratory prediction model.

Abdominal radiology (New York)·2026

Clinical impact of CT-defined sarcopenia on long-term oncological outcomes in gastric cancer: validation of muscle mass cut-offs established according to EWGSOP recommendations.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2026

External validation of a top-ranked model from the RSNA pulmonary embolism detection challenge: assessment of generalizability.

Scientific reports·2026

Analgosedation in interventional radiology.

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2026

Extravertebral temperature exposure during spinal radiofrequency ablation: an experimental surrogate assessment of neural injury risk.

Archives of orthopaedic and trauma surgery·2026

CAD-RADS 2.0: Comparison of methods for assessment of plaque burden.

European journal of radiology open·2026

See all related articles